Research Associate / Senior Research Associate, Therapeutic Technologies at Addition Therapeutics | South San Francisco, USA | Rezi

Research Associate / Senior Research Associate, Therapeutic Technologies at Addition Therapeutics

Research Associate / Senior Research Associate, Therapeutic Technologies

Addition Therapeutics · South San Francisco, USA

Today

Research Associate / Senior Research Associate, Therapeutic Technologies

Addition Therapeutics · South San Francisco, USA

6 hours ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

This is a hands-on, bench-focused role where you will produce RNA reagents and run cell-based assays to evaluate their performance. The ideal candidate is a versatile experimentalist skilled in in vitro transcription (IVT), mammalian cell culture, and end-to-end cell-based assays. You will collaborate with cross-functional teams to drive the company's core experimental engine.

Responsibilities

  • Produce research-grade RNA by in vitro transcription (IVT) at routine cadence and scale, including template preparation, transcription, capping and tailing, DNase treatment, and purification.
  • Release RNA material against defined quality specifications.
  • Perform RNA quality control (concentration, purity, and integrity) using spectrophotometry, fluorometry, and electrophoretic/capillary methods.
  • Maintain mammalian cell lines and disease-relevant models, ensuring assay-ready cells are available on schedule.
  • Deliver PRINT RNA into cells via transfection, lipofection, and electroporation/nucleofection across multiple cell types.
  • Execute readout assays including reporter assays, ELISA, qPCR/ddPCR, flow cytometry, and high-content imaging.
  • Analyze, plot, and document results clearly in the electronic lab notebook, flagging anomalies and contributing to troubleshooting.
  • Support assay optimization and modest throughput scale-up, including work with liquid-handling automation.
  • Assist with lab operations, including reagent and consumable inventory, sample and reagent tracking, and instrument upkeep.

Requirements

  • Bachelor's or Master's degree in molecular biology, biochemistry, cell biology, biotechnology, or a related field.
  • Approximately 2–5 years of hands-on laboratory experience, with industry experience preferred.
  • Strong, current mammalian cell culture skills, including sterile technique, maintenance of multiple cell lines, and transfection.
  • Hands-on molecular biology experience, including RNA handling and RNase-free technique.
  • Demonstrated reliability, organization, and attention to detail, producing reproducible data and documenting it clearly.
  • Ability to manage multiple concurrent tasks in a fast-paced environment.
  • Ability to communicate results to a cross-functional team.

Skills

  • In vitro transcription (IVT)
  • Mammalian cell culture
  • Cell-based assays
  • RNA handling
  • RNase-free technique
  • Reporter assays
  • ELISA
  • qPCR/ddPCR
  • Flow cytometry
  • High-content imaging
  • Spectrophotometry
  • Fluorometry
  • Electrophoretic/capillary methods
  • Transfection
  • Lipofection
  • Electroporation/nucleofection
  • Electronic lab notebook
  • Liquid-handling automation
  • Automated liquid handling (e.g., Biomek, Echo)
  • High-throughput assay workflows
  • Secreted-protein or hormone assays
  • Gene therapy
  • mRNA
  • RNA-based therapeutic modalities
  • Data analysis in R, Python, GraphPad Prism, or similar

Location

  • South San Francisco

Work Type

  • Full-time
  • Onsite

Experience Level

  • Research Associate
  • Senior Research Associate
  • 2-5 years

Education Level

  • Bachelor's degree
  • Master's degree

Salary/Compensations

  • $98,000–$130,000

Benefits

  • Bonus eligibility
  • Equity incentives
  • Benefits

About the Company

  • Addition Therapeutics is at the forefront of biotechnology innovation, building the next generation of gene therapy using our proprietary PRINT™ (Precise RNA-mediated Insertion of Transgenes) platform.
  • Our PRINT™ platform redefines genetic medicine by enabling the development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome.
  • We are a Series A-stage company advancing programs across rare and common diseases.

Equal Opportunity

  • Addition Therapeutics is an equal opportunity employer.
  • We value diverse perspectives and are committed to building an inclusive team.